Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01897571 |
|---|---|
| Brief Title: | Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Adv. Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With DLBCL |
| First Submitted : | June 21, 2013 |
| First Submitted that Met QC Criteria : | July 9, 2013 |
| First Posted : | July 12, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 5, 2021 |
| Last Update Posted : | January 7, 2021 |